Given that NF-κB is elevated in AD, PD, and ASD patients, aberrant or varying levels of butyrate in patients with gut dysbiosis may indirectly lead to dysregulation of NF-κB expression, leading to increased neuroinflammation in these patients [95]. Here, NFKB1 is linked to Parkinson disease.